Relative myotoxic and haemodynamic effects of the β‐agonists fenoterol and clenbuterol measured in conscious unrestrained rats
Open Access
- 2 November 2006
- journal article
- Published by Wiley in Experimental Physiology
- Vol. 91 (6), 1041-1049
- https://doi.org/10.1113/expphysiol.2006.035014
Abstract
The β2‐adrenoceptor (β2‐AR) agonists clenbuterol and fenoterol have similar beneficial effects in animal models of heart failure. However, large doses of clenbuterol can induce cardiomyocyte death, and it is not known which of these agents has the most favourable therapeutic profile. We have investigated the cardiotoxicity of clenbuterol and fenoterol alongside that of isoprenaline, and compared their haemodynamic effects. Wistar rats (n= 6 per group) were subcutaneously injected with each β‐agonist (0.003–3 mmol kg−1) or saline, and cardiomyocyte apoptosis was detected by caspase 3 immunohistochemistry. In a separate experiment, rats (n= 4) were given equivalent doses to those used in the myotoxicity studies, in a randomized cross‐over design, and their blood pressure recorded via radiotelemetry. Injection of 0.3 mmol kg−1 fenoterol or isoprenaline, but not clenbuterol, induced significant cardiomyocyte apoptosis (0.4 ± 0.05%; P < 0.05). At 3 mmol kg−1, all agonists induced apoptosis (fenoterol, 1.1 ± 0.1%; isoprenaline, 0.9 ± 0.8%; and clenbuterol, 0.4 ± 0.07%; P < 0.05). β1‐Adrenoceptor antagonism (10 mg kg−1 bisoprolol) prevented 92% (P < 0.05) of apoptosis induced by all three agonists, but clenbuterol‐induced apoptosis could also be prevented by 96% (P < 0.05) by β2‐AR antagonism (10 mg kg−1 ICI 118 551). Clenbuterol decreased diastolic (1.3‐ to 1.6‐fold; P < 0.05) and systolic blood pressure (1.3‐fold; P < 0.05), and doses > 0.3 mmol kg−1 increased heart rate (1.4‐fold; P < 0.05). Fenoterol increased heart rate (1.2‐ to 1.4‐fold; P < 0.05), and doses > 0.3 mmol kg−1 decreased diastolic blood pressure (1.3‐fold; P < 0.05). In conclusion, the cardiotoxicity of fenoterol was similar to isoprenaline and greater than clenbuterol, and fenoterol had less desirable haemodynamic effects.This publication has 39 references indexed in Scilit:
- Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivoJournal of Molecular and Cellular Cardiology, 2005
- Dose‐dependent apoptotic and necrotic myocyte death induced by the β2‐adrenergic receptor agonist, clenbuterolMuscle & Nerve, 2005
- β2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscleJournal of Applied Physiology, 2005
- The Effect of the β2-Adrenoceptor Agonist Prodrug BRL-47672 on Cardiovascular Function, Skeletal Muscle Myosin Heavy Chain, and MyoD Expression in the RatThe Journal of pharmacology and experimental therapeutics, 2004
- Characterization of Adrenoceptor Involvement in Skeletal and Cardiac Myotoxicity Induced by Sympathomimetic Agents: Toward a New Bioassay for β-blockersJournal of Cardiovascular Pharmacology, 2003
- Appraisal of the Role of Angiotensin II and Aldosterone in Ventricular Myocyte Apoptosis in Adult Normotensive RatJournal of Molecular and Cellular Cardiology, 2002
- β-Adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of β1-adrenoceptor densityInternational Journal of Cardiology, 2000
- Clenbuterol and Anabolic SteroidsSouthern Medical Journal, 1998
- β2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial AgonistsOnline Journal of Public Health Informatics, 1997
- The ??2-Agonist ControversyDrug Safety, 1994